From: Differences and similarities between cancer and somatic stem cells: therapeutic implications
Tumor type | Markers |
---|---|
Leukemia | CD34+ [191, 196,197,198]; CD38− [191, 197, 198]; CD47+ [191]; CCL-1 [191]; CD96+ [36, 191]; CD90− [198]; CD117− [198]; CD133+ [199]; CD123+ [191, 198] |
Breast | CD34+ [200]; CD24low [36, 48, 191, 197]; ALDH1+ [198]; CD29+ [201]; Bmi-1+ [202]; CD133+ [48]; ESA+ [191, 198]; CD59+ [36] |
Pancreatic | ESA+ [48, 191]; CD24+ [48, 191, 198]; CD44+ [48, 191, 198]; CD133+ [36, 48, 198] |
Lung | CD44+ [48, 191]; CD133+ [48, 191, 198, 203]; CD59+ [36]; CD56+ [203] |
Liver | ESA+ [191]; CD133+ [48, 191, 198]; CD90+ [191, 198]; CD44+ [48, 191]; CD176+ [48] |
Gastric | |
Colorectal | ESA+ [191]; CD133+ [36, 48, 191, 198, 205]; CD166+ [48, 191, 198]; CD44+ [48, 191, 198]; CD24+ [48, 191, 198] |
Prostate | Integrin α2β1 [48]; CD44+ [48, 198]; CD133+ [48, 198]; Bmi-1 [206] |
Melanoma | |
Ovarian | CD44+ [48, 197, 208]; CD117+ [48, 197, 208]; CD133+ [48, 208]; CD24+ [48] |